NDC11 68462020013
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 68462-0200-13 | 68462-0200 |
| 68462-200-13 | 68462-200 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Telmisartan | TELMISARTAN | Glenmark Pharmaceuticals Inc., USA | c6eb489d-2946-4c14-839f-d4af761ead31 | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | 68462-200-13 68462-200 68462020013 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.